These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19900653)

  • 1. Stroke prevention by cilostazol in patients with atherothrombosis: meta-analysis of placebo-controlled randomized trials.
    Uchiyama S; Demaerschalk BM; Goto S; Shinohara Y; Gotoh F; Stone WM; Money SR; Kwon SU
    J Stroke Cerebrovasc Dis; 2009; 18(6):482-90. PubMed ID: 19900653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of adjunctive cilostazol to dual antiplatelet therapy after stent implantation: an updated meta-analysis of randomized controlled trials.
    Ding XL; Xie C; Jiang B; Gao J; Zhang LL; Zhang H; Zhang JJ; Miao LY
    J Cardiovasc Pharmacol Ther; 2013 May; 18(3):222-8. PubMed ID: 23263383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilostazol for peripheral arterial disease.
    Robless P; Mikhailidis DP; Stansby GP
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003748. PubMed ID: 17253494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of cilostazol versus aspirin for the secondary prevention of stroke.
    Dinicolantonio JJ; Lavie CJ; Fares H; Menezes AR; O'Keefe JH; Bangalore S; Messerli FH
    Am J Cardiol; 2013 Oct; 112(8):1230-4. PubMed ID: 23827403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cilostazol for peripheral arterial disease.
    Robless P; Mikhailidis DP; Stansby GP
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003748. PubMed ID: 18254032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit of cilostazol in patients with high risk of bleeding: subanalysis of cilostazol stroke prevention study 2.
    Uchiyama S; Shinohara Y; Katayama Y; Yamaguchi T; Handa S; Matsuoka K; Ohashi Y; Tanahashi N; Yamamoto H; Genka C; Kitagawa Y; Kusuoka H; Nishimaru K; Tsushima M; Koretsune Y; Sawada T; Hamada C
    Cerebrovasc Dis; 2014; 37(4):296-303. PubMed ID: 24820203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Cilostazol Therapy in Ischemic Stroke: A Meta-analysis.
    Tan L; Margaret B; Zhang JH; Hu R; Yin Y; Cao L; Feng H; Zhang Y
    J Stroke Cerebrovasc Dis; 2015 May; 24(5):930-8. PubMed ID: 25804574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cilostazol on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials.
    Geng DF; Deng J; Jin DM; Wu W; Wang JF
    Atherosclerosis; 2012 Jan; 220(1):177-83. PubMed ID: 22015232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic study of cilostazol on secondary stroke prevention: a meta-analysis.
    Qian Y; Bi Q
    Eur J Med Res; 2013 Dec; 18(1):53. PubMed ID: 24313983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilostazol: potential mechanism of action for antithrombotic effects accompanied by a low rate of bleeding.
    Goto S
    Atheroscler Suppl; 2005 Dec; 6(4):3-11. PubMed ID: 16275169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cilostazol for secondary stroke prevention: systematic review and meta-analysis.
    Tan CH; Wu AG; Sia CH; Leow AS; Chan BP; Sharma VK; Yeo LL; Tan BY
    Stroke Vasc Neurol; 2021 Sep; 6(3):410-423. PubMed ID: 33542092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial.
    Toyoda K; Uchiyama S; Hoshino H; Kimura K; Origasa H; Naritomi H; Minematsu K; Yamaguchi T;
    Int J Stroke; 2015 Feb; 10(2):253-8. PubMed ID: 25487817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cilostazol-based triple antiplatelet therapy compared to dual antiplatelet therapy in patients with coronary stent implantation: a meta-analysis of 5,821 patients.
    Geng DF; Liu M; Jin DM; Wu W; Deng J; Wang JF
    Cardiology; 2012; 122(3):148-57. PubMed ID: 22832561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cilostazol in secondary prevention of stroke: impact of the Cilostazol Stroke Prevention Study.
    Matsumoto M
    Atheroscler Suppl; 2005 Dec; 6(4):33-40. PubMed ID: 16275125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of randomized controlled trials appraising the efficacy and safety of cilostazol after coronary artery stent implantation.
    Jang JS; Jin HY; Seo JS; Yang TH; Kim DK; Kim DS; Kim DK; Seol SH; Kim DI; Cho KI; Kim BH; Park YH; Je HG; Jeong YH; Kim WJ; Lee JY; Lee SW
    Cardiology; 2012; 122(3):133-43. PubMed ID: 22832424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new antiplatelet agent cilostazol--what is the evidence for its use and tolerability?
    Sidddiqi SA; Kamal AK
    J Pak Med Assoc; 2012 Jan; 62(1):78-9. PubMed ID: 22352114
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of cilostazol for secondary stroke prevention: an old dog with new tricks?
    Ansara AJ; Shiltz DL; Slavens JB
    Ann Pharmacother; 2012 Mar; 46(3):394-402. PubMed ID: 22353234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy and safety of cilostazol: a critical review of the literature.
    Rogers KC; Oliphant CS; Finks SW
    Drugs; 2015 Mar; 75(4):377-95. PubMed ID: 25758742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilostazol Versus Aspirin for Secondary Stroke Prevention: Systematic Review and Meta-Analysis.
    Lin MP; Meschia JF; Gopal N; Barrett KM; Ross OA; Ertekin-Taner N; Brott TG
    J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105581. PubMed ID: 33388632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.